Robert remains one of the team's prominent litigators, with particular experience of complex IP disputes and advising clients from a range of IP rich industries.
Rob is a partner and co-head of our Intellectual Property Group in London.
He has significant experience in both contentious and non-contentious IP work, advising on the full range of issues relating to patents, copyright, trade marks, designs and trade secrets/confidential information. He also jointly leads our International Trade Secrets Protection Group.
Rob has particular experience of complex IP disputes (with a focus on multi-jurisdictional patent litigation and trade secrets disputes) and has advised clients from a range of IP rich industries, including life sciences, energy and utilities, speciality chemicals, mechanical engineering and electronics on various strategic IP issues including lifecycle management.
He was a member of the teams acting for Pfizer in patent cases concerning the blockbuster products Viagra and Lipitor, and acted for Synthon in its action against GSK concerning paroxetine mesylate, which resulted in one of the leading House of Lords judgments on the law of novelty in the UK. He also acted for BP Chemicals in two actions against Hoechst Celanese relating to acetic acid production and for Sir Robert McAlpine in a high profile passing off dispute with Alfred McAlpine. Other significant cases he has handled have been for Synthon in an action relating to the SPC for Memantine and for Rovi Corp in a patent dispute with Virgin Media concerning electronic programme guides. Most recently he has been acting for Allergan in a dispute concerning patents covering the use of botulinum toxin products for the treatment of urinary incontinence conditions and for DS Smith PLC in a patent case relating to wheeled pallet products used in the FMCG industry.
Rob obtained a BSc degree in Chemistry and Law, and a BA degree in Law from Exeter University before undertaking his training with us. He has written and spoken on a range of IP topics and is an associate of the Chartered Institute of Patent Attorneys (CIPA) and the Institute of Trade Mark Attorneys (ITMA).